Treatment strategies for acute coronary syndrome with severe mitral regurgitation and their effects on short- and long-term prognosis

Ko Long Lin, Shih Hung Hsiao, Chieh Jen Wu, Pei Leun Kang, Kuan Rau Chiou

Research output: Contribution to journalArticle

Abstract

Mitral regurgitation (MR) of even mild severity affects the prognosis of patients with acute coronary syndrome (ACS). The present study retrospectively analyzed 1,142 patients with ACS and MR of varying severity. Of the 95 patients with severe MR, 57 (60%) underwent primary percutaneous coronary intervention only and 38 (40%) underwent coronary artery bypass grafting (CABG) and mitral valve replacement (MVR). The severity of MR was significantly associated with the risk of heart failure but not with in-hospital or long-term mortality. In patients with severe MR, in-hospital mortality was no greater in those treated with CABG and MVR than in those treated with percutaneous coronary intervention alone. However, the incidence of long-term hard events (heart failure and all-cause mortality) was lower in those who had received the combined treatment. Multivariate analysis showed that, compared to percutaneous coronary intervention alone, CABG combined with MVR at the acute phase of ACS resulted in a significantly improved prognosis (odds ratio 0.172, 95% confidence interval 0.046 to 0.649, p = 0.009), even after adjusting for age, left ventricular filling pressure, and ejection fraction. In conclusion, the severity of MR in patients with ACS is associated with long-term heart failure events. Even at the acute phase of ACS, CABG combined with MVR results in an acceptable in-hospital mortality rate. The combined strategy also reduced the long-term hard events.

Original languageEnglish
Pages (from-to)800-806
Number of pages7
JournalAmerican Journal of Cardiology
Volume110
Issue number6
DOIs
Publication statusPublished - Sep 15 2012
Externally publishedYes

Fingerprint

Mitral Valve Insufficiency
Acute Coronary Syndrome
Mitral Valve
Coronary Artery Bypass
Percutaneous Coronary Intervention
Heart Failure
Hospital Mortality
Mortality
Therapeutics
Ventricular Pressure
Multivariate Analysis
Odds Ratio
Confidence Intervals
Incidence

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Treatment strategies for acute coronary syndrome with severe mitral regurgitation and their effects on short- and long-term prognosis. / Lin, Ko Long; Hsiao, Shih Hung; Wu, Chieh Jen; Kang, Pei Leun; Chiou, Kuan Rau.

In: American Journal of Cardiology, Vol. 110, No. 6, 15.09.2012, p. 800-806.

Research output: Contribution to journalArticle

@article{9ef47fabec2547c6a62d1c5f9e7ff779,
title = "Treatment strategies for acute coronary syndrome with severe mitral regurgitation and their effects on short- and long-term prognosis",
abstract = "Mitral regurgitation (MR) of even mild severity affects the prognosis of patients with acute coronary syndrome (ACS). The present study retrospectively analyzed 1,142 patients with ACS and MR of varying severity. Of the 95 patients with severe MR, 57 (60{\%}) underwent primary percutaneous coronary intervention only and 38 (40{\%}) underwent coronary artery bypass grafting (CABG) and mitral valve replacement (MVR). The severity of MR was significantly associated with the risk of heart failure but not with in-hospital or long-term mortality. In patients with severe MR, in-hospital mortality was no greater in those treated with CABG and MVR than in those treated with percutaneous coronary intervention alone. However, the incidence of long-term hard events (heart failure and all-cause mortality) was lower in those who had received the combined treatment. Multivariate analysis showed that, compared to percutaneous coronary intervention alone, CABG combined with MVR at the acute phase of ACS resulted in a significantly improved prognosis (odds ratio 0.172, 95{\%} confidence interval 0.046 to 0.649, p = 0.009), even after adjusting for age, left ventricular filling pressure, and ejection fraction. In conclusion, the severity of MR in patients with ACS is associated with long-term heart failure events. Even at the acute phase of ACS, CABG combined with MVR results in an acceptable in-hospital mortality rate. The combined strategy also reduced the long-term hard events.",
author = "Lin, {Ko Long} and Hsiao, {Shih Hung} and Wu, {Chieh Jen} and Kang, {Pei Leun} and Chiou, {Kuan Rau}",
year = "2012",
month = "9",
day = "15",
doi = "10.1016/j.amjcard.2012.05.010",
language = "English",
volume = "110",
pages = "800--806",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Treatment strategies for acute coronary syndrome with severe mitral regurgitation and their effects on short- and long-term prognosis

AU - Lin, Ko Long

AU - Hsiao, Shih Hung

AU - Wu, Chieh Jen

AU - Kang, Pei Leun

AU - Chiou, Kuan Rau

PY - 2012/9/15

Y1 - 2012/9/15

N2 - Mitral regurgitation (MR) of even mild severity affects the prognosis of patients with acute coronary syndrome (ACS). The present study retrospectively analyzed 1,142 patients with ACS and MR of varying severity. Of the 95 patients with severe MR, 57 (60%) underwent primary percutaneous coronary intervention only and 38 (40%) underwent coronary artery bypass grafting (CABG) and mitral valve replacement (MVR). The severity of MR was significantly associated with the risk of heart failure but not with in-hospital or long-term mortality. In patients with severe MR, in-hospital mortality was no greater in those treated with CABG and MVR than in those treated with percutaneous coronary intervention alone. However, the incidence of long-term hard events (heart failure and all-cause mortality) was lower in those who had received the combined treatment. Multivariate analysis showed that, compared to percutaneous coronary intervention alone, CABG combined with MVR at the acute phase of ACS resulted in a significantly improved prognosis (odds ratio 0.172, 95% confidence interval 0.046 to 0.649, p = 0.009), even after adjusting for age, left ventricular filling pressure, and ejection fraction. In conclusion, the severity of MR in patients with ACS is associated with long-term heart failure events. Even at the acute phase of ACS, CABG combined with MVR results in an acceptable in-hospital mortality rate. The combined strategy also reduced the long-term hard events.

AB - Mitral regurgitation (MR) of even mild severity affects the prognosis of patients with acute coronary syndrome (ACS). The present study retrospectively analyzed 1,142 patients with ACS and MR of varying severity. Of the 95 patients with severe MR, 57 (60%) underwent primary percutaneous coronary intervention only and 38 (40%) underwent coronary artery bypass grafting (CABG) and mitral valve replacement (MVR). The severity of MR was significantly associated with the risk of heart failure but not with in-hospital or long-term mortality. In patients with severe MR, in-hospital mortality was no greater in those treated with CABG and MVR than in those treated with percutaneous coronary intervention alone. However, the incidence of long-term hard events (heart failure and all-cause mortality) was lower in those who had received the combined treatment. Multivariate analysis showed that, compared to percutaneous coronary intervention alone, CABG combined with MVR at the acute phase of ACS resulted in a significantly improved prognosis (odds ratio 0.172, 95% confidence interval 0.046 to 0.649, p = 0.009), even after adjusting for age, left ventricular filling pressure, and ejection fraction. In conclusion, the severity of MR in patients with ACS is associated with long-term heart failure events. Even at the acute phase of ACS, CABG combined with MVR results in an acceptable in-hospital mortality rate. The combined strategy also reduced the long-term hard events.

UR - http://www.scopus.com/inward/record.url?scp=84865482187&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865482187&partnerID=8YFLogxK

U2 - 10.1016/j.amjcard.2012.05.010

DO - 10.1016/j.amjcard.2012.05.010

M3 - Article

VL - 110

SP - 800

EP - 806

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 6

ER -